| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |